Objective-To examine the contribution of HIV infection to the apparently increasing incidence of tuberculosis in central Africa.
Introduction
Over the past few years tuberculosis has emerged as an important disease in people infected with HIV. Increases in the numbers of new cases of tuberculosis have been recorded in the United States,' Tanzania, Burundi,2 and Zambia, and seroprevalence surveys have indicated a strong link between tuberculosis and HIV.24 The activation of latent infection with organisms acquired early in life and exposed by deteriorating immune control is characteristic of AIDS.' In many developing countries latent infection with tuberculosis is present in most adults,6 and in these countries the spread of HIV may cause a major secondary epidemic of active tuberculosis.
In Zambia, therefore, we have embarked on a series ofstudies ofthe interaction between the two organisms, and in this paper we present the findings of an initial cross sectional study undertaken to establish the prevalence of HIV-1 infection among patients with tuberculosis in Lusaka and to examine the impact of HIV infection on the clinical presentation of tuberculosis.
Patients and methods

PATIENTS
Patients with tuberculosis in Lusaka and the surrounding areas are notified and kept under review at the chest clinic of the University Teaching Hospital in Lusaka. Patients arriving at the clinic wait in line to be seen by one of three or four clinical officers or doctors.
Between November 1988 and January 1989 all the adult patients being treated for tuberculosis seen by one doctor were asked to take part in the study; they were selected on the basis simply of being next in line. A questionnaire relating to history and clinical examination was completed for each patient, radiological and laboratory results were recorded, and a blood sample was taken. Serological testing was carried out anonymously, all clinical and laboratory data being identified only by a number.
In all, 360 eligible patients were seen. Eight patients refused to take part and two (both of whom had had positive HIV antibody results) were considered too sick to be subjected to the interview. Four The association between HIV infection and certain other variables was studied. After allowing for age and sex, a high prevalence of HIV infection was found to be significantly associated with a high number of years spent in full time education, good housing (a low number of people sharing the same bedroom), divorced or widowed marital state, and history of previous treatment for sexually transmitted diseases (table II). All these associations remained significant when joint effects between them were examined. Table III shows the prevalence of HIV antibody according to category of tuberculosis; patients in whom more than one site was affected are included in the table under each site. A much higher prevalence of HIV antibody was found among those with pleural or pericardial disease than among those with pulmonary disease, and, although patients with pleural or pericardial disease were younger than those with pulmonary disease, the difference in HIV state was independent of age and sex. This was shown by comparing those with pleural or pericardial disease, or both, with or without pulmonary disease, with those with pulmonary disease but no pleural or pericardial disease (odds ratio corrected for age and sex=3-5 (1-7 to 5.9); p<0-001).
TUBERCULOSIS
Results of sputum culture were positive in 126 patients and not available for three. The results of sputum smear examinations were compared in 62 patients positive for HIV and 61 negative for HIV (table IV) . Only 39 (63%; 51% to 75%) of those positive for HIV had had a positive smear compared with 50 (82%; 72% to 92%) of those negative for HIV (X2=4-67) df= 1; p<005). Among patients with a positive sputum smear there was a tendency for those who were HIV positive to show a lower count of bacilli (table IV; X2 for trend=3 34, df= 1; p=0 07).
Chest radiographs were available for 139 of the 149 patients with pulmonary tuberculosis confirmed by sputum smear or culture, or both (table V) . Of these 
Discussion
The strong link between tuberculosis and HIV has been shown in seroprevalence surveys in places as diverse as Burundi, the United States, Tanzania, and Haiti,2 and in our study the prevalence of antibody in patients_with tuberculosis in Lusaka, at 60%, was found to be considerably higher than the 10% found in blood donors from the same area over the
Both Mycobactenrum tuberculosis and HIV have their impact on young adults at the beginning, or in the prime, of their productive lives; the largest numbers of cases of tuberculosis and the highest percentage of patients with HIV antibody were women aged 14 to 24 and men aged 25 to 34 years. Half of the patients screened were from the better educated sector of the population (eight or more years in full time education); in this group the prevalence of HIV antibody was higher than that in those with less education.
The seriousness of these observations need not be emphasised. There is evidence from several sources, however, that tuberculosis may respond well to treatment, even in the presence of HIV infection.9 '°It is therefore essential that the diagnosis should be made and appropriate treatment given.
The classic form of tuberculosis, with cavitating, upper zone, pulmonary lesions, is known to be determined by the interaction between the bacillus and the host's immune system, so that in the presence of immune deficiency a different outcome may be expected. The A real impediment to the successful treatment of tuberculosis is the development of severe adverse drug reactions, and patients with concurrent HIV infection seem to be particularly at risk. This is shown in our study by the occurrence of Stevens-Johnson syndrome exclusively in patients positive for HIV. It has been widely speculated that thiacetazone is the drug responsible for most of these serious rashes,'4" but this is not yet proved. Hypersensitivity to any antituberculous drug may cause a rash, and studies in which treatment did not include thiacetazone have also shown a greater incidence of adverse drug reactions among patients positive for HIV. 9 16 If, however, it is true that one drug is responsible for most drug reactions then it should be clearly identified so that its use in patients positive for HIV may be avoided.
Another 
Introduction
Place of death and quality of final care are important components of terminal cancer care for both the patient and the family. The proportion of patients with cancer dying at home has fallen steadily in the United Kingdom, from 37% in 1965 to 27% in 1987.' In Edinburgh and Western Australia, however, the provision of cancer care services has enabled as many as 41% and 70% respectively ofpatients with cancer to die at home.23 There are no studies in the United Kingdom reporting patient preferences about place of terminal care.
This study was therefore undertaken to determine prospectively the needs and wishes of patients who were dying from cancer, their symptoms and symptom BMJ VOLUME 301 1 SEPTEMBER 1990
